Phase 3Completed

The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study

Sponsor
AstraZeneca (Industry)
Enrollment
10 planned
Conditions
Hypercholesterolemia
Interventions
Rosuvastatin; aortic pulse wave velocity measurements
Ages
adults, older adults
Registry
NCT00240279

Full record on ClinicalTrials.gov

From the registry

To investigate the effect of rosuvastatin compared to placebo on the aortic stiffness in hemodialysis patients as measured by pulse wave velocity (at 3, 6 and 12 months)

Primary outcomes

  • To investigate the effect of rosuvastatin compared to placebo on the aortic stiffness in hemodialysis patients as measured by pulse wave velocity (at 3, 6 and 12 months)

History

  1. Last registry update

  2. Primary completion

  3. Registered

  4. Started